Answers are grounded in this paper and cite their sources.
Cross-sectional study demonstrates HFLC's correlation with dengue severity in patients, suggesting its potential use in clinical settings.
Introduction: Dengue affects 2.5 billion people globally, with symptoms ranging from mild flu-like illness to fatal Dengue Hemorrhagic Fever (DHF). Diagnosis is confirmed using Dengue virus ELISA IgM and NS1 antigen. High Fluorescent Lymphocyte Count (HFLC), measured using the Sysmex XN-1000 hematology analyzer, provides a faster, cost-effective, and accurate alternative to ELISA and NS1 tests. Study Aims: 1. To determine HFLC in Dengue Fever (DF) and DHF patients using the Sysmex XN-1000. 2. To assess the correlation of HFLC with thrombocytopenia, particularly from day 1 to day 5 of infection. Methods: A cross-sectional study was conducted at two tertiary care hospitals in India (Aug–Oct 2024) with IEC approval. A total of 52 patients of all ages, positive for NS1 antigen and/or ELISA IgM, were included. Routine venous blood samples were analyzed via Sysmex XN-1000. Data on CBC, total cell count, hemoglobin, liver enzymes, and HFLC were tabulated in Excel and analyzed using SPSS 20.0. Results: Among 52 DF patients, HFLC ranged from 0.1–20.3%, with a mean of 8.5%. Of these, 15 had DHF, showing low HFLC (0.1–3.2%), averaging 1.2% (TABLE 1), correlating with high NS1 titers and reduced immune response. A significant difference in HFLC% between DF and DHF patients was observed (p < 0.01). Low HFLC% at diagnosis indicates higher risk of DHF-related complications, making it useful for early severity assessment. HFLC was higher in patients with fever >5 days, correlating with high IgM titers. Abnormal USG findings (e.g., gallbladder wall edema/capillary leak) were seen in 33% and significantly correlated with HFLC (p = 0.001). DHF patients with low HFLC had longer hospital stays (8 ± 2.2 days), which was statistically significant (p < 0.5). Conclusions: HFLC is a promising research parameter for assessing Dengue severity. This is the first known study to report a positive correlation between HFLC and thrombocytopenia in DHF patients, with limited prior literature available.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: